NCT01436032View on ClinicalTrials.gov

Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

PHASE3TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Laparoscopic Surgery
Interventions
DRUG

N1539

IV

DRUG

N1539

IV

DRUG

N1539

IV

DRUG

Ketorolac Tromethamine

IV

DRUG

Placebo

IV

Trial Locations (1)

91105

Lotus Clinical Research LLC, Pasadena

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY